The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNorthern Jiangsu People's Hospital

About this trial

In this study, the investigators compared the improvement of liver reserve function related indicators in patients with liver cirrhosis after laparoscopic splenectomy. To determine whether surgical treatment can help enhance postoperative liver reserve function and improve patient prognosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

A clinical, radiological or histologic diagnosis of cirrhosis of any etiology

Splenomegaly with secondary hypersplenism, Platelet count < 50*10^9/L

Informed consent to participate in the study

Disqualifiers

Hepatocellular carcinoma or any other malignancy,

Child-Pugh grade C

Recent peptic ulcer disease

History of Hemorrhagic stroke

Trial design

Design model

Single group

Treatments tested in this trial

  • Laparoscopic splenectomy

    Procedure/Surgery

    The laparoscopic splenectomy was performed by the same surgical team.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Experimental GroupOther 1 intervention

Trial outcomes

Primary outcomes

1

Liver reserve function ICG-K level at 3 months after surgery

The level of liver reserve function ICG-K level at 3 months after surgery.

Time frame
3 months
2

Liver reserve function ICG-K level at 6 months after surgery.

The level of liver reserve function ICG-K level at 6 months after surgery.

Time frame
6 months
3

Liver reserve function ICG-K level at 12 months after surgery

The level of liver reserve function ICG-K level at 12 months after surgery.

Time frame
12 months
4

Liver reserve function ICG-K level at 24 months after surgery.

The level of liver reserve function ICG-K level at 24 months after surgery.

Time frame
24 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.